We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-10.95%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.5B
AUM Growth
-$293M
Cap. Flow
-$295M
Cap. Flow %
-11.83%
Top 10 Hldgs %
36.69%
Holding
119
New
16
Increased
26
Reduced
20
Closed
21

Top Buys

Rank Stock Value
1
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$120M
2
VTRS icon
Viatris
VTRS
+$32.1M
3
VCEL icon
Vericel Corp
VCEL
+$31.5M
4
AGN
Allergan plc
AGN
+$29.5M
5
ACRS icon
Aclaris Therapeutics
ACRS
+$28.9M

Top Sells

Rank Stock Value
1
DBVT
DBV Technologies
DBVT
+$65.1M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
+$62.4M
3
ACHC icon
Acadia Healthcare
ACHC
+$27.8M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$26.9M
5
RGNX icon
Regenxbio
RGNX
+$20.8M

Sector Composition

Rank Sector Weight
1 Healthcare 69.79%
2 Financials 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKD icon
26
Brookdale Senior Living
BKD
$3.58B
$28.4M 1.14%
4,240,855
-467,057
-10% -$3.92M
GKOS icon
27
Glaukos
GKOS
$9.21B
$28.3M 1.13%
504,000
-65,356
-11% -$3.93M
BPMC
28
DELISTED
Blueprint Medicines
BPMC
$28.1M 1.12%
521,000
-4,000
-0.8% -$243K
RARX
29
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$27.3M 1.09%
1,502,000
+1,119,300
+292% +$17.6M
LKFT
30
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
$26.5M 1.06%
288,407
+28,343
+11% +$2.87M
EDIT icon
31
Editas Medicine
EDIT
$457M
$26.4M 1.06%
1,158,841
– –
IMMU
32
DELISTED
Immunomedics Inc
IMMU
$26.2M 1.05%
1,833,202
+243,202
+15% +$4.83M
DFBHU
33
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
$25.3M 1.01%
2,500,000
– –
ELV icon
34
Elevance Health
ELV
$80.9B
$24.9M 1%
95,000
– –
AGN
35
DELISTED
Allergan plc
AGN
$24.1M 0.96%
+180,000
New +$29.5M
FATE icon
36
Fate Therapeutics
FATE
$324M
$21.2M 0.85%
1,654,865
+481,248
+41% +$6.71M
SEM
37
DELISTED
Select Medical
SEM
$21.2M 0.85%
2,566,644
-265,612
-9% -$2.54M
TNDM icon
38
Tandem Diabetes Care
TNDM
$1.17B
$21M 0.84%
553,765
+270,650
+96% +$9.56M
RETA
39
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$20.4M 0.82%
364,000
+70,000
+24% +$4.27M
SIEN
40
DELISTED
Sientra, Inc.
SIEN
$20M 0.8%
157,289
+97,912
+165% +$18.2M
MOH icon
41
Molina Healthcare
MOH
$11.7B
$17.6M 0.71%
+151,772
New +$19.9M
NTRA icon
42
Natera
NTRA
$38.9B
$17.5M 0.7%
+1,253,000
New +$22.9M
INSP icon
43
Inspire Medical Systems
INSP
$1.46B
$16.9M 0.68%
400,781
+211,781
+112% +$9M
ACHC icon
44
Acadia Healthcare
ACHC
$3.17B
$16M 0.64%
621,000
-803,571
-56% -$27.8M
ADUS icon
45
Addus HomeCare
ADUS
$2.14B
$15.8M 0.63%
232,900
+167,310
+255% +$11.4M
MOR
46
DELISTED
MorphoSys AG American Depositary Shares
MOR
$15.2M 0.61%
600,000
– –
KALV
47
DELISTED
KalVista Pharmaceuticals
KALV
$12.8M 0.51%
650,000
– –
DCPH
48
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12.8M 0.51%
+607,633
New +$14.9M
ARVN icon
49
Arvinas
ARVN
$517M
$11.8M 0.47%
921,234
-312,500
-25% -$4.96M
GWPH
50
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.6M 0.43%
109,117
+79,868
+273% +$10.5M
1
2
3 4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q4 2018 Portfolio in Review

As of Q4 2018, Deerfield Management held 119 positions worth $2.5B, down 11% from $2.79B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Deerfield Management withdrew a net $295M in Q4 2018, closing 21 positions and reducing 20 holdings. Its most notable exit was DBV Technologies, an estimated $65.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 69% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Orchard Therapeutics plc American Depositary Shares worth $126M.

  • Deerfield Management's largest Q4 2018 buy was Orchard Therapeutics plc American Depositary Shares: 802,360 shares worth $126M.
  • Deerfield Management added most to Viatris in Q4 2018, an estimated $32.1M increase.
  • Deerfield Management's biggest Q4 2018 reduction was Acadia Healthcare, cutting an estimated $27.8M.
  • Deerfield Management fully exited DBV Technologies in Q4 2018, selling an estimated $65.1M.
  • Deerfield Management's ten largest holdings make up 37% of its $2.5B portfolio in Q4 2018.
  • Deerfield Management opened 16 new positions and closed 21 in Q4 2018.
  • Deerfield Management's portfolio value fell 11% quarter-over-quarter to $2.5B.

Based on Deerfield Management's 13F filing for Q4 2018, filed 14 Feb 2019.